FDA allows Houston cancer doctor to resume drug trial
Por um escritor misterioso
Descrição
Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw
Feeling Like Death': Inside a Houston Hospital Bracing for a Virus Peak - The New York Times
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
FDA panel: Benefit of 'highly anticipated' lung cancer drug can't be interpreted reliably
Sen. Sanders pushes NIH to rein in drug prices
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation
When Cancer Patients Ask About Weed, Many Doctors Say Go For It – Houston Public Media
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
Fast-Track Drug Approval, Designed for Emergencies, Is Now Routine - WSJ
GoLocalProv FDA Closes Last Option for 20-Year-Old RI Cancer Patient Facing Death
New Drugs for Ovarian Cancer Patients - WSJ
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Oncology
Doctor claims to cure pediatric cancer, critics skeptical
Brian_Wice
de
por adulto (o preço varia de acordo com o tamanho do grupo)